Contemplate the data and tweets to guess whether the closing price of $bmy will surge or decline at 2017-02-03. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-01-20,12.7,12.7,-0.6,-11.3,-11.3,11.0,15.0,16.6,17.2,17.5,16.9
2017-01-23,-0.9,0.6,-1.7,1.6,1.6,6.8,11.3,13.7,14.6,15.1,14.7
2017-01-24,2.2,2.4,-0.1,-2.1,-2.1,6.1,11.4,14.9,16.1,16.8,16.8
2017-01-25,-0.4,0.0,-1.5,1.2,1.2,2.2,8.0,12.2,13.7,14.7,14.9
2017-01-26,3.8,5.7,-1.7,-5.5,-5.5,4.5,12.2,17.0,19.0,20.3,20.9
2017-01-27,-1.0,1.8,-1.3,2.0,2.0,1.8,8.2,13.0,15.7,17.1,18.0
2017-01-30,-1.0,0.8,-1.5,2.0,2.0,-0.7,4.5,9.3,12.4,14.0,15.0
2017-01-31,-1.5,0.5,-1.9,1.0,1.0,-1.6,2.1,6.8,10.4,12.2,13.3
2017-02-01,-0.3,0.1,-2.0,0.3,0.3,-1.9,0.4,5.1,9.1,11.1,12.4
2017-02-02,-2.3,0.8,-2.4,2.5,2.5,-2.8,-3.0,1.7,5.7,7.7,9.2

2017-01-20: is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|rt AT_USER $bmy, where art thou? not in first-line lung cancer immunotherapy, sadly -&gt; |rt 
2017-01-21: $bmy sum put vol=5,592 sum call vol=2,406 putcallratio=2.32 expiration 01/27/2017 .  |$bmy far too oversold.  likely to bounce nicely. |rt AT_USER on the fly: top stock stories for friday $ge $pg $ibm
2017-01-22: #bristolmyerssquibb procter &amp; gamble, skyworks gain; bristol-myers squibb sinks. read more:  $bmy|#bristolmyerssquibb procter &amp; gamble, skyworks gain; bristol-myers squibb sinks. read more:  $
2017-01-23: AT_USER hi pete - are you still long $bmy ??|rt AT_USER buy $bmy? |q4 earnings are upon us. here's what to expect from those reporting this week  $abbv $biib $bmy $celg $jnj $nvs $vrtx|q4 earnings are
2017-01-24: 3q16 = 16% qoq &amp; 28% peak (4q15) decline in total hcv sales. will 4q16 hcv sales for $gild $abbv $mrk $bmy continue¡­ |i should say $bmy earnings on thursday. getting ahead of myself. |rt AT_USER 
2017-01-25: rt AT_USER $bmy key growth drivers are opdivo and eliquis, opdivo has taken nsclc hit (keytruda), but eliquis is gaining strength¡­|rt AT_USER $bmy opdivo growth seems to be hanging in there even afte
2017-01-26: rt AT_USER interesting chart showing pharma price increases more aggressive than biotech increase $ibb $gild $celg $incy $lly $mr¡­|rt AT_USER interesting chart showing pharma price increases more agg
2017-01-27: #bristolmyerssquibb bristol-myers squibb company given new $60.00 price target at jefferies ... read more:  $bmy|#bristolmyerssquibb bristol-myers squibb company given new $60.00 price target at jeffe
2017-01-28: rt AT_USER news: large gains with weed microcap stocks. read:  $bmy $nxpi $mbly $mar $idu $hban $mpw $emes¡­|is bristol-meyers a buy after 39% price decline? $mrk also $bmy |is bristol-meyers a buy af
2017-01-29: is bristol-myers a buy after 39% price decline? $bmy |AT_USER maybe until mystic reads out and creates more confusion for $bmy holders|is bristol-myers a buy after 39% price decline?  $bmy|rt AT_USER 
2017-01-30: rt AT_USER weekend review video 1/29 $vix $tlt $ibb $bmy $spy $iwm $qqq $msft $goog $aapl $amzn $fb $nflx $tsla $nvda $pcln $gs ht¡­|investment counsel inc. buys 1,552 shares of bristol-myers squibb c
2017-01-31: 2/1 wl $drys $catb $mnta $aezs $tenx $fb $tsla $dis $jnug $dcix $ua $bmy $nugt $jdst $s $bac $nymt $ebay $pypl sham¡­ |scan results - 1,2,3 retracement bearish today: $bt $vivo $bmy $prgo $mnk ... |#b
2017-02-01: rt AT_USER $bmy just said it assumes $mrk will be successful in getting keytruda + chemo combo approval on keynote-021|$mjn  ..  vulnerable and gone ............  $bmy  is in same fix ....|rt AT_USER 
2017-02-02: $bmy: bristol-myers confirms fda approval for opdivo (nivolumab) in previously treated locally advanced or... |the AT_USER granted accelerated approval to #nivolumab (opdivo, $bmy company) for treatme
Answer:
date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-01-20,12.7,12.7,-0.6,-11.3,-11.3,11.0,15.0,16.6,17.2,17.5,16.9
2017-01-23,-0.9,0.6,-1.7,1.6,1.6,6.8,11.3,13.7,14.6,15.1,14.7
2017-01-24,2.2,2.4,-0.1,-2.1,-2.1,6.1,11.4,14.9,16.1,16.8,16.8
2017-01-25,-0.4,0.0,-1.5,1.2,1.2,2.2,8.0,12.2,13.7,14.7,14.9
2017-01-26,3.8,5.7,-1.7,-5.5,-5.5,4.5,12.2,17.0,19.0,20.3,20.9
2017-01-27,-1.0,1.8,-1.3,2.0,2.0,1.8,8.2,13.0,15.7,17.1,18.0
2017-01-30,-1.0,0.8,-1.5,2.0,2.0,-0.7,4.5,9.3,12.4,14.0,15.0
2017-01-31,-1.5,0.5,-1.9,1.0,1.0,-1.6,2.1,6.8,10.4,12.2,13.3
2017-02-01,-0.3,0.1,-2.0,0.3,0.3,-1.9,0.4,5.1,9.1,11.1,12.4
2017-02-02,-2.3,0.8,-2.4,2.5,2.5,-2.8,-3.0,1.7,5.7,7.7,9.2

2017-01-20: is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|rt AT_USER $bmy, where art thou? not in first-line lung cancer immunotherapy, sadly -&gt; |rt 
2017-01-21: $bmy sum put vol=5,592 sum call vol=2,406 putcallratio=2.32 expiration 01/27/2017 .  |$bmy far too oversold.  likely to bounce nicely. |rt AT_USER on the fly: top stock stories for friday $ge $pg $ibm
2017-01-22: #bristolmyerssquibb procter &amp; gamble, skyworks gain; bristol-myers squibb sinks. read more:  $bmy|#bristolmyerssquibb procter &amp; gamble, skyworks gain; bristol-myers squibb sinks. read more:  $
2017-01-23: AT_USER hi pete - are you still long $bmy ??|rt AT_USER buy $bmy? |q4 earnings are upon us. here's what to expect from those reporting this week  $abbv $biib $bmy $celg $jnj $nvs $vrtx|q4 earnings are
2017-01-24: 3q16 = 16% qoq &amp; 28% peak (4q15) decline in total hcv sales. will 4q16 hcv sales for $gild $abbv $mrk $bmy continue¡­ |i should say $bmy earnings on thursday. getting ahead of myself. |rt AT_USER 
2017-01-25: rt AT_USER $bmy key growth drivers are opdivo and eliquis, opdivo has taken nsclc hit (keytruda), but eliquis is gaining strength¡­|rt AT_USER $bmy opdivo growth seems to be hanging in there even afte
2017-01-26: rt AT_USER interesting chart showing pharma price increases more aggressive than biotech increase $ibb $gild $celg $incy $lly $mr¡­|rt AT_USER interesting chart showing pharma price increases more agg
2017-01-27: #bristolmyerssquibb bristol-myers squibb company given new $60.00 price target at jefferies ... read more:  $bmy|#bristolmyerssquibb bristol-myers squibb company given new $60.00 price target at jeffe
2017-01-28: rt AT_USER news: large gains with weed microcap stocks. read:  $bmy $nxpi $mbly $mar $idu $hban $mpw $emes¡­|is bristol-meyers a buy after 39% price decline? $mrk also $bmy |is bristol-meyers a buy af
2017-01-29: is bristol-myers a buy after 39% price decline? $bmy |AT_USER maybe until mystic reads out and creates more confusion for $bmy holders|is bristol-myers a buy after 39% price decline?  $bmy|rt AT_USER 
2017-01-30: rt AT_USER weekend review video 1/29 $vix $tlt $ibb $bmy $spy $iwm $qqq $msft $goog $aapl $amzn $fb $nflx $tsla $nvda $pcln $gs ht¡­|investment counsel inc. buys 1,552 shares of bristol-myers squibb c
2017-01-31: 2/1 wl $drys $catb $mnta $aezs $tenx $fb $tsla $dis $jnug $dcix $ua $bmy $nugt $jdst $s $bac $nymt $ebay $pypl sham¡­ |scan results - 1,2,3 retracement bearish today: $bt $vivo $bmy $prgo $mnk ... |#b
2017-02-01: rt AT_USER $bmy just said it assumes $mrk will be successful in getting keytruda + chemo combo approval on keynote-021|$mjn  ..  vulnerable and gone ............  $bmy  is in same fix ....|rt AT_USER 
2017-02-02: $bmy: bristol-myers confirms fda approval for opdivo (nivolumab) in previously treated locally advanced or... |the AT_USER granted accelerated approval to #nivolumab (opdivo, $bmy company) for treatme